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Abstract We report the cloning and functional expression of a 
novel K + channel ~-subunit from human atrium, hKv~13, hKv/33 
is highly homologous to the two D-subunits cloned from rat brain, 
Kv/]l and Kv~2, but has an essentially unique stretch of 79 
N-terminal residues. Upon expression in Xenopus oocytes, 
hKvi~3 accelerates the inactivation of co-injected hKvl.4 currents 
and induces fast inactivation of non-inactivating co-injected 
hKvl.5 currents. By contrast, hKvi~13 had no effect on hKvl.1, 
hKvl.2, or hKv2.1 currents. Thus, hKv/]3 represents a third type 
of K ÷ channel ~-subunit which modulates the kinetics of a unique 
subset of channels in the Kv| subfamily. 
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channel genes are expressed in the heart [10], yet little is known 
about the molecular basis of individual cardiac K ÷ currents. 
Here we have examined human atrium for the presence of K + 
channel/3-subunit sequences, and report the cloning of a novel 
member of this family, hKvfl3. Through heterologous expres- 
sion in Xenopus oocytes, the functional effects of this accessory 
subunit on a number of human K + channels, including the 
voltage-gated channels hKvl.1,  hKvl .2,  hKvl.4,  hKvl.5,  and 
hKv2.1, have been examined. We find that hKvfl3 specifically 
modulates the kinetics of hKvl .5 and hKvl.4. The existence of 
multiple fl-subunits with specific functional effects on K ÷ chan- 
nel subsets brings a new perspective to the search for the link 
between K + channel gene products and native currents. 
2. Materials and methods 
1. Introduction 
Voltage-gated ion channels are formed by a pore-forming 
~-subunit the functional characteristics of which may be mod- 
ified by one or more accessory proteins [1]. In the case of Na + 
channels, the kinetic properties of the ~-subunit may be altered 
by one or more fl-subunits [2]. For Ca 2+ channels, a variety of 
accessory proteins, including ~2-& 7, and four different -sub- 
units have been described [1]. K ÷ channels have been shown to 
associate with accessory subunits as well [3,4], and two mem- 
bers of a new family of fl-subunits which interact with K ÷ 
channels have recently been cloned [5,6]. Rat brain Kvfll intro- 
duces inactivation into a non-inactivating delayed rectifier K ÷ 
channel, Kv 1.1, and accelerates the inactivation of a fast-inac- 
tivating K ÷ channel, Kvl.4, while no effect on K ÷ channel 
kinetics has been described for Kvfl2 [6]. K ÷ channels constitute 
the most diverse group of ion channels [7,8], and modulatory 
fl-subunits might serve to increase the functional diversity of K ÷ 
currents. Thus, characterizing the interaction of fl-subunits 
with K + channel gene products is a critical step in determining 
the molecular composition of individual native K + currents. 
Cardiac K ÷ currents are crucial to the maintenance of the 
complex electrical activity of the heart [9]. A variety of K + 
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2.1. Cloning of hKvfl3 from human atrium 
Specimens of atrial appendages were obtained from adult patients 
undergoing coronary bypass urgery. Total RNA was extracted using 
RNA-Stat 60 (Tel-Test Inc., Houston, TX) according to the manufac- 
turer's protocol. Poly(A) + RNA was isolated from total RNA with the 
oligo-dT-based Messenger RNA Isolation Kit (Stratagene). A mixture 
of oligo(dT)~2 18 primers and random hexamers [pd(N)6 ] was used to 
prime first strand cDNA synthesis from 10/.tg poly(A) + RNA using the 
TimeSaver cDNA Synthesis Kit (Pharmacia). Construction of the 
cDNA library was done with the cDNA Synthesis Kit from Stratagene. 
120 ng of double-stranded cDNA (>700 bp), following fraetionation on 
Sephacryl S-400, was ligated to 1 /tg EeoRI-CIAP treated 2-ZAPII 
vector (Stratagene). The ligation product was packaged in Phagemaker 
In Vitro Packaging System (Novagen), and resulted in 1 x 10 6 inde- 
pendent recombinant clones. The unamplified library was screened at 
low stringency for sequences homologous to bovine Kv/~2. The probe, 
bovine Kvfl2 cDNA [1], was obtained by RT-PCR from bovine brain 
poly(A) ÷ RNA (Clontech), and 32p random prime labelled (Multiprime 
DNA Labeling System; Amersham). Hybridization was for 16-18 h at 
45°C in RapidHyb buffer (Amersham) at a probe concentration of 
3 x 10 6 cpm/ml, and the filters were washed at 45°C with 1 × SSC, 0.1% 
SDS (1 x SSC contains 150 mM NaC1, 15 mM sodium citrate, pH 7.0). 
Three positive clones were isolated, and the pBluescript SK(-) plasmids 
excised from A-ZAPII. The clone with the longest insert, 2.6 kb, was 
sequenced in its entirety in both directions, and found to contain a 
single open reading frame encoding 408 amino acids with homology to 
rat and bovine Kvfl subunits. 
2.2. Expression of hKv~3 cRNA in Xenopus oocytes 
To boost the expression of hKvfl3 in oocytes, the hKvfl3 cDNA was 
subcloned into an expression vector which contains a poly(A)+-tail, 
A+-pCRII [14]. The coding region of hKvfl3 was amplified by PCR to 
facilitate cloning into the ApaI-EeoRI sites of A÷-pCRII. The hKvfl3 
PCR product was sequenced completely and found to be identical to 
the original clone. 
Complementary RNA (cRNA) for injection into oocytes was pre- 
pared as previously described following linearization of the plasmid 
with BamHI [10]. The origin of the cDNAs co-injected with hKvfl3 is 
as follows, hKvl.5 was previously cloned in our laboratory [11], and 
subcloned into A÷-pCRII for oocyte expression, hKvl.4 was obtained 
by RT-PCR of human heart total RNA using oligonucleotides derived 
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from the published sequence [12], sequenced, and subcloned into 
A+-pCRII. hKv 1.1 and hKv 1.2 were kindly provided by O. Pongs. For 
oocyte expression, the coding region of hKv 1.1 was amplified by PCR, 
sequenced, and subcloned into A+-pCRII. We cloned hKv2.1 from a 
human brain cDNA library, and found the predicted amino acid se- 
quence to be consistent with the published sequence [13]. Oocytes were 
injected with 46 nl of cRNA at concentrations ranging from 50 to 150 
ng/ml. Weight ratios of hKvfl3 : K + channel cRNAs of 1 : 1.2 : 1, and 4:1 
were tested with comparable results. 
Macroscopic currents were recorded in oocytes voltage-clamped with 
two intracellular microelectrodes as previously described [14]. No linear 
leakage and capacity current subtraction was performed unless speci- 
fied. The external bathing solution consisted of either (in mM): 
NMDG, 122.5; MES, 122.5; MgCI2-H20 , 2.5; HEPES, 10 pH 7.4: or 
NMDG, 22.5; KOH, 100; MES, 122.5; MgCI2-H~O, 2.5, HEPES 
pH 7.4. 
3. Results and discussion 
3.1. cDNA isolation and sequence analysis 
To probe for the expression of K + channel fl-subunit se- 
quences in human heart, we screened a human atrial cDNA 
library with a fragment derived from the coding region of bo- 
vine brain Kvfl2. Under conditions of low stringency we iso- 
lated three positive clones, one of which contained a 2.6 kb 
insert. This clone, hKvfl3, when sequenced in its entirety in 
both directions, was shown to encompass a complete opening 
reading frame of 1224 bp (Fig. 1A). The clone contains 68 bases 
of putative 5' untranslated sequence, as well as approximately 
1.3 kb of untranslated sequence at the 3' end (only a small 
portion is shown). There is an in-frame stop codon (TGA)just 
3 bases upstream of the presumed start ATG, indicating that 
the 2.6 kb clone contains the entire coding sequence. 
The open reading frame of hKvfl3 predicts a protein of 408 
amino acids with significant homology to bovine Kvfl2 as well 
as rat Kvfll and Kvfl2 (Fig. 1B). Over the C-terminal 329 amino 
acids, hKvfl3 is 100% identical to rat brain Kvfll, and 85% 
identical to both bovine and rat brain Kvfl2. The three types 
of fl-subunits differ, however, in the length and sequence of 
their N-terminal regions, hKvfl3 has an N-terminal region of 
79 amino acids, slightly longer than the N-terminus of ill (72 
amino acids) and twice the length offl2 (38 residues). Virtually 
no homology exists between the N-terminal regions offl2 and 
f13, but two regions of the N-terminus of hKvfl3 can be aligned 
with the putative ball peptide sequence [15,16] of ill, as shown 
in Fig. 1C. Both alignments have been made relative to a con- 
....> 
Fig. 1. Primary Structure of hKvfl3. (A) Nucleotide and predicted 
amino acid sequence of hKvfl3 eDNA. Nucleotides are numbered be- 
ginning with the first base of the initiating methionine codon, ATG. 
Only a small stretch of the 3' untranslated sequence is shown. There is 
one potential phosphorylation site for cAMP-dependent protein kinase 
(R/K-X-X-S/T) at S150, and ten potential sites for protein kinase C 
(S/T-X-R/K) at S13, T71, T157, T168, S173, T228, $293, $303, $307 
and $402. The hKvfl3 sequence has been submitted to the Genbank 
(accession umber U16953). (B) Alignment of the deduced amino acid 
sequence of hKvfl3 with rat Kvfll, rat Kvfl2 and bovine Kvfl2. Residues 
identical to hKvfl3 are denoted with a colon (:). (C) Alignment of the 
two putative ball peptide sequences of hKvfl3 with the reported ball 
sequence of Kvfll. Two stretches in the N-terminus of hKvfl3 (amino 
acids 1-27 and amino acids 37-59) have been aligned separately with 
the ball peptide sequence of Kvfll (residues 1-25). Identical residues are 
marked with a colon (:) and conservative substitutions, based on 
charge, polarity and hydrophobicity, are indicated with a vertical ine 
(I). The conserved C (cysteine) residue is marked with an arrow. 
served cysteine residue (marked with an arrow). Rat Kvfll has 
a cluster of positively charged residues (K and R) following the 
cysteine residue, as do both regions of hKvfl3. Thus, hKvfl3 
may contain two ball peptide-like sequences whereas rat fll has 
only one. 
3.2. Functional expression of hKv~3 in Xenopus oocytes 
To investigate the functional role of hKvfl3 in human heart, 
(A) 
5', .... GGCAAGATACAGTG~TCTTAAAGTTAAGCACC GTGCAATTAC~ ~-*  -*-+-+-+~AAAC 61 
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(m) 
hK~3- ~ILYKP~.ADIPSPKLGLPKSSESALKCRWHLAVTKTQPQAACK~SGAAEQKYVEKFLRVHGISI~ 70 
rK~l- MQVSIACTE~z:RNGEDRLLSKQSS:APNVVN:ARAKFRTV:IIARSLGT:TPQ:H:::K: 63 
rK~2- MYPESTTGSP:RLSLROTGSP~IY:TRy 29 
bK~2- MYPEgTTGSP:RLSLROTGSP~IY:TR¥ 29 
hK,~3- TTRAETGMAYRNLGKSGLRVSCLGLGTW~ISDEVAZRLMTIAYESG~AEVYA~KAEVIL  140 
rK~l- ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 133 
hK~3- :SIIKKKGWRRSSLVITTKLYWGGKAETERGLSRKHZIEGLKGSL~EYV~ANRPDS~TFg~EX 210 
rK~l- : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :  203 
rK~2- :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 169 
bK~2- :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 169 
hK~3-VRAMTHVIN~TSRWSAMEIMEAYSVARQF~IPPVCEOAEYMLFQRRKV~LPELYHKIGVG 280 
rK~l- :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 273 
bK~2+ :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 239 
hK~3- AMTWSPLACGI ISGKYGNGVPESSR~LKCI~IVSE~GRKQ~LSPIAERLGCTLPQLAVA 350 
rK~l -  : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :  343 
rK~2- : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :  309 
b~2-  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 309 
hK~3- WCLRNEGVSSVLLGSSTPEQL~LGA~QVLPKMTSHVVNEIZ~NILRNKPYSKKDYRS 408 
rK~l- :::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 401 
rK~2- ::::::::::::::::NA:::::::::::::::::::::::::::::::::::::::: 367 
b~2-  ::::::::::::::::SAD::::::::::::::::::::::::::::::::::::::: 367 
(c> [ 
hK~3- i MHLYKpACADI P SKLGL PKS SESAL - - KC 27 
: 11 I : : I I I  I : I  I I I ;  : : 
rK~l- 1 MQVS - IACTEHNLKS - - - RNGEDRLL SKQ 25 
hK~3- 37 TQ PQAAC ..... KP~P SGAEOKYVEK. 59 
~:t  I : :  : I :  I r :  I I : 
r~l- i M~VSZAC~K-Sm--~RLLSK0 25 
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Fig. 2. Effect of hKvfl3 on human K ÷ channels hKvl.4 and hKvl.5. 
(A) Families of currents recorded from hKvl.4 (left) and hKvh4 co- 
expressed with hKvfl3 (right), stepping from -60 mV to +40 mV with 
I0 mV steps from a holding potential of -80 mV. (B) K* currents 
recorded from oocytes injected with hKvl.5 (left) and hKvl.5 plus 
hKvfl3 (right). The recordings were obtained by stepping from a hold- 
ing potential of -80 mV with 10 mV steps from -60 mV to +90 inV. 
A P/4 subtraction was used to correct for leakage and capacitance 
currents only in the record in the left panel. 
we heterologously expressed hKvfl3 in Xenopus oocytes in the 
presence of a variety of K + channel subunits. Initially we exam- 
ined the interaction of hKvfl3 with a fast inactivating channel, 
hKvl.4, which expresses an A-type current when expressed in 
Xenopus oocytes (Fig. 2A, left). When co-injected with hKvfl3, 
inactivation of hKvl.4 currents was accelerated at potentials 
ranging from +20 to +80 mV (Fig. 2A, right). The currents were 
best fitted to a double exponential function. The faster time 
constant was 2-3 times smaller than that calculated for hKv 1.4 
alone (at +70 mV, vl = 13.5 _+ 1.9 ms for hKvl.4 plus hKvfl3 
compared to 39.8 _+ 10.2 ms for hKvl.4 alone, P < 0.01; at +40 
mV, r l  = 22.8 _+ 3.6 ms for hKvl.4 plus hKvfl3 compared to 
39.9 _+ 5.8 ms for hKvl.4, P < 0.05; n = 5-8). The slower time 
constant, f2, was also decreased in the presence of hKvfl3 (at 
+70 mV, r2 -- 62.1 + 3.0 ms for hKvl.4 plus hKvfl3 compared 
to 117.4 _+ 31.8 ms for hKvl.4 alone, P> 0.05; at +40 mV, 
~'2-- 77.8_+ 5.8 for hKvl.4 plus hKvfl3 compared to 
119.5 + 27.5 for hKvl.4 alone, P > 0.05; n = 5 8). In compari- 
son, when fitted to a single exponential, Kvfll decreases the ri 
of Kvl.4 approximately six-fold at +50 mV [6]. 
We also examined the effects of hKvfl3 on the delayed recti- 
fier hKvl.5, which exhibits little inactivation during a 200 ms 
pulse (Fig. 2B, left). Upon co-expression with hKvfl3, fast inac- 
tivation of the whole-cell currents appeared (Fig. 2B, right; 
n--16) at very depolarized potentials (+30 to +90 mV): 
13.0 + 0.2% and 36.0 + 0.2% of the whole-cell currents were 
inactivated at +40 mV and +90 mV, respectively (n= 25). The 
current decay was best fitted with a double exponential func- 
tion. The faster time constant (rl) (3.83 + 0.1 ms at +90 mV; 
3.50 + 0.2 ms at +40 mV; n = 11) was not voltage-dependent 
(P > 0.05), whereas the slower time constant (r2) was voltage- 
dependent with values of 39.7 + 4.3 ms at +90 mV and 
94.0_ + 10.7 ms at +40 mV (P< 0.001; n= 11). In addition, 
unlike hKv1.4, the level ofhKv1.5 currents appeared to be five- 
to ten-fold lower in the presence of hKvfl3. The reason for this 
effect is presently unknown. 
Of the channels examined in the Kvl subfamily, hKvfl3 was 
specific for hKvl.4 and hKvl.5. Two other human channels, 
hKv 1.1 and hKv 1.2, generate non-inactivating delayed rectifier 
currents when expressed in oocytes, but, as illustrated in Fig. 
3A and B, no inactivation was observed at potentials up to +80 
mV (n = 31 and 20, respectively) when either channel was co- 
expressed with hKvfl3. Furthermore, hKvfl3 had no observable 
effect on the expression levels of either Kvl.1 or Kvl.2 currents, 
The specificity of hKvfl3 was further confirmed in co-injec- 
tion experiments with the voltage-gated elayed rectifier, 
hKv2.1. No effects on inactivation or level of expression of 
whole-cell currents were observed when hKvfl3 was co-injected 
with equal amounts of hKv2.1 cRNA (Fig. 3C; n = 8). We also 
examined two inward rectifiers which share homology in the H5 
or putative pore region with voltage-gated K + channels, IRK1 
[17] and hIRK, cloned from human atrium [18]. No kinetic 
changes in the presence of hKvfl3 at potentials ranging from 
-120 mV to +50 mV were observed (data not shown). Finally, 
currents from oocytes injected with hKvfl3 resembled those of 
uninjected oocytes (Fig. 3D). 
The human heart clone, hKvfl3, constitutes the third member 
of a newly described fl-subunit gene family, hKvfl3 affects the 
kinetic properties of hKvl.5 and hKvl.4, both of which are 
expressed in heart [19]. Kvl.2 and Kv2.1 are also expressed in 
heart [19], yet, interestingly, hKvfl3 has no apparent effect on 
the inactivation properties of these two channels or on hKvl. 1, 
which is abundantly expressed in the brain [20]. Thus, hKvfl3 
is able to differentially affect members of the Kvl subfamily. 
The specificity of hKvfl3 is different from that observed for 
rat brain Kvfll, which introduces fast inactivation i to Kvl.1 
and accelerates the inactivation of Kvl.4 [6]. The proposed 
mechanism for Kvfll induced inactivation is through a ball 
peptide-like sequence in the N-terminus. hKvfl3 is identical to 
Kvfll except in the N-terminal region, however, sequence align- 
ments within this region indicate that hKvfl3 may actually pos- 
sess two ball peptide-like sequences. Mutational analysis in this 
region may bring insight into the mechanism and specificity of 
hKvfl3. 
For heart, one of the unanswered questions i the molecular 
nature of the channels that underlie the transient outward cur- 
rent,/to [21,22]. Heteromultimeric assembly of specific K + chan- 
nel subunits has been shown to generate inactivating currents 
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A hKv 1.1 hKv 1.1 + 133 C hKv 2.1 hKv2.1 +133 
,80 f 
f 
f 
f 
r 
S 
20000 nA 
20 ms 
+80 
B D 
hKv 1.2 hKv 1.2 + 133 uninjected 
,+60 mV 
÷ 60 mV 
20 ms 
133 a lone 
l'i o 
20 ms 
[1000 nA 
5O ms 
-60,~1;0 
[1000 nA 
60 ms 
-120,+80 
Fig. 3. Effects of hKvfl3 on hKv 1.1, hKv 1.2 and hKv2.1. (A) hKvl. 1 (left) and hKv 1.1 plus hKvfl3 currents recorded with 10 mV steps from -60 
mV to +80 mV from a holding potential of -60 mV. P/4 substraction was performed to correct for leakage and capacitance currents. (B) hKvl.2 
(left) and hKvl.2 plus hKvfl3 (right) currents elicited by the same pulse protocol described in A. A P/4 subtraction protocol was also applied to these 
records. (C) Whole-oocyte currents recorded from hKv2.1 alone (left) or in the presence of hKvfl3 (right) with 10 mV steps from -60 mV to +60 
mV from a holding potential of -60 inV. (D) Currents recorded from either uninjected oocytes (left) or oocytes injected with cRNA encoding hKvfl3 
alone. 
which resemble, but do not reproduce ntirely, the properties 
of native /to [23]. The interaction of endogenous cardiac fl- 
subunits with K + channel gene products might provide the 
missing molecular component of Ito currents. 
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